IDEXX Laboratories Company Insiders

IDEXX Laboratories' latest congressional trading

IDEXX Laboratories Management Team Effectiveness

The company has return on total asset (ROA) of 0.2559 % which means that it generated a profit of $0.2559 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.662 %, meaning that it created $0.662 on every $100 dollars invested by stockholders. IDEXX Laboratories' management efficiency ratios could be used to measure how well IDEXX Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to 0.33 in 2026. Return On Capital Employed is likely to rise to 0.65 in 2026. At this time, IDEXX Laboratories' Return On Assets are fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 93.2 M in 2026. Net Income Applicable To Common Shares is likely to rise to about 820 M in 2026The majority of IDEXX Laboratories outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in IDEXX Laboratories to benefit from reduced commissions. Thereupon, third-party entities are subject to a different set of regulations than regular investors in IDEXX Laboratories. Please pay attention to any change in the institutional holdings of IDEXX Laboratories as this could imply that something significant has changed or is about to change at the company. On February 3, 2026, Representative April Delaney of US Congress acquired under $15k worth of IDEXX Laboratories's common stock. Some institutional investors establish a significant position in stocks such as IDEXX Laboratories in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of IDEXX Laboratories, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

IDEXX Laboratories Workforce Comparison

IDEXX Laboratories Profit Margins

The company has Profit Margin (PM) of 0.25 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.29 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.29.

IDEXX Laboratories Insider Trading History

IDEXX Laboratories Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as IDEXX Laboratories often depends on how effective the management is. IDEXX Laboratories management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of IDEXX management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the IDEXX management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in IDEXX Laboratories' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of IDEXX Laboratories. Check IDEXX Laboratories' Beneish M Score to see the likelihood of IDEXX Laboratories' management manipulating its earnings.

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.